Sensible MedicineThis Fortnight in Medicine XXIX1×0:00Current time: 0:00 / Total time: -37:28-37:28Audio playback is not supported on your browser. Please upgrade.This Fortnight in Medicine XXIXTreating MSSA and a new way to treat HFrEF (not really)Adam Cifu, MD, John Mandrola, and Andrew J FoyJul 01, 2026ShareTranscriptCefazolin for Methicillin-Susceptible Staphylococcus aureus BacteremiaStopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysisThe Impact of Midodrine on Guideline-Directed Medical Therapy in Patients Admitted With Systolic Heart FailureDiscussion about this episodeCommentsRestacksSensible MedicineCommon sense and original thinking in bio-medicine A platform for diverse views and debateCommon sense and original thinking in bio-medicine A platform for diverse views and debateSubscribeListen onSubstack AppRSS FeedAppears in episodeAndrew J FoyWrites Andrew J Foy SubscribeAdam Cifu, MDJohn MandrolaRecent EpisodesThis Fortnight in Medicine XXVIIIJun 17 • Adam Cifu, MD and Vinay PrasadThis Fortnight in Medicine XXVIIJun 3 • Adam Cifu, MD, Vinay Prasad, and Andrew J FoyThis Fortnight in Medicine XXVIMay 20 • John Mandrola, Vinay Prasad, and Andrew J FoyThis Fortnight in Medicine XXVMay 6 • Adam Cifu, MD, John Mandrola, and Andrew J FoyThis Fortnight in Medicine XXIVApr 22 • Adam Cifu, MD, John Mandrola, and Andrew J FoyThis Fortnight in Medicine XXIIIApr 8 • Adam Cifu, MD, John Mandrola, and Andrew J FoyThis Fortnight in Medicine XXIIMar 24 • Adam Cifu, MD, John Mandrola, and Andrew J Foy